Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1987 1
1990 1
1991 3
1992 3
1993 5
1994 2
1996 4
1997 7
1998 4
1999 6
2000 3
2001 2
2002 7
2003 5
2004 6
2005 10
2006 8
2007 13
2008 12
2009 14
2010 13
2011 25
2012 24
2013 27
2014 39
2015 33
2016 34
2017 24
2018 27
2019 27
2020 27
2021 29
2022 22
2023 7

Text availability

Article attribute

Article type

Publication date

Search Results

417 results

Results by year

Filters applied: . Clear all
Page 1
Obesity, type 2 diabetes, and testosterone in ageing men.
Wittert G, Grossmann M. Wittert G, et al. Rev Endocr Metab Disord. 2022 Dec;23(6):1233-1242. doi: 10.1007/s11154-022-09746-5. Epub 2022 Jul 14. Rev Endocr Metab Disord. 2022. PMID: 35834069 Free PMC article. Review.
Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year randomized clinical trial.
Tay J, Thompson CH, Luscombe-Marsh ND, Wycherley TP, Noakes M, Buckley JD, Wittert GA, Yancy WS Jr, Brinkworth GD. Tay J, et al. Among authors: wittert ga. Diabetes Obes Metab. 2018 Apr;20(4):858-871. doi: 10.1111/dom.13164. Epub 2017 Dec 20. Diabetes Obes Metab. 2018. PMID: 29178536 Clinical Trial.
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.
Wittert G, Bracken K, Robledo KP, Grossmann M, Yeap BB, Handelsman DJ, Stuckey B, Conway A, Inder W, McLachlan R, Allan C, Jesudason D, Fui MNT, Hague W, Jenkins A, Daniel M, Gebski V, Keech A. Wittert G, et al. Lancet Diabetes Endocrinol. 2021 Jan;9(1):32-45. doi: 10.1016/S2213-8587(20)30367-3. Lancet Diabetes Endocrinol. 2021. PMID: 33338415 Clinical Trial.
Anti-obesity drugs.
Rankin W, Wittert G. Rankin W, et al. Among authors: wittert g. Curr Opin Lipidol. 2015 Dec;26(6):536-43. doi: 10.1097/MOL.0000000000000232. Curr Opin Lipidol. 2015. PMID: 26382553 Review.
417 results